Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury
Status:
Completed
Trial end date:
2020-08-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of calcifediol (25-hydroxyvitamin D) and
calcitriol (1,25-dihydroxyvitamin D) in preventing and reducing the severity of acute kidney
injury (AKI) in critically ill patients.
Phase:
Phase 2
Details
Lead Sponsor:
David Leaf
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)